Woodstock Corp’s Ironwood Pharmaceuticals IRWD Stock Holding History

Woodstock Corp’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-33,926	Closed	-$455K	–	165
2015 Q1	$455K	Hold	33,926	–	–	0.08%	120
2014 Q4	$435K	Hold	33,926	–	–	0.08%	124
2014 Q3	$368K	Sell	33,926 -23,454	-41%	-$269K	0.07%	135
2014 Q2	$737K	Hold	57,380	–	–	0.13%	110
2014 Q1	$592K	Hold	57,380	–	–	0.11%	118
2013 Q4	$558K	Hold	57,380	–	–	0.1%	117
2013 Q3	$569K	Buy	57,380 +10,560	+23%	+$104K	0.11%	113
2013 Q2	$389K	Buy	+46,820	New	+$567K	0.08%	130

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Woodstock Corp's IRWD Position: Q2 2015 in Review

Woodstock Corp sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2015, closing a stake of 33,926 shares — an estimated $455K sold.

Woodstock Corp first reported a position in IRWD in Q2 2013 and held it in 8 quarters. The position peaked at $737K in Q2 2014. 137 funds tracked by Wall St. Rank hold IRWD as of Q2 2015.

Woodstock Corp reported no remaining Ironwood Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Woodstock Corp sold 33,926 Ironwood Pharmaceuticals shares in Q2 2015, an estimated $455K.
Woodstock Corp first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Woodstock Corp's Ironwood Pharmaceuticals position peaked at $737K in Q2 2014.
137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2015.

Based on Woodstock Corp's 13F filing for Q2 2015, filed 7 Jul 2015.